Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 09:00 am Sale | 2024-12-31 | 13G | Axsome Therapeutics, Inc. AXSM | RTW INVESTMENTS LP | 4,051,365 8.400% | -438,231 (-9.76%) | Filing History |
| 2024-02-14 3:46 pm Purchase | 2023-12-31 | 13G | Axsome Therapeutics, Inc. AXSM | Fairmount Funds Management LLC | 2,360,077 4.900% | 15,097 (+0.64%) | Filing History |
| 2024-02-14 07:26 am Purchase | 2023-12-31 | 13G | Axsome Therapeutics, Inc. AXSM | RTW INVESTMENTS LP | 4,489,596 9.500% | 1,509,114 (+50.63%) | Filing History |
| 2024-02-13 4:58 pm Purchase | 2023-12-29 | 13G | Axsome Therapeutics, Inc. AXSM | VANGUARD GROUP INC | 3,696,766 7.810% | 279,138 (+8.17%) | Filing History |
| 2024-01-26 5:25 pm Purchase | 2023-12-31 | 13G | Axsome Therapeutics, Inc. AXSM | BlackRock Inc. BLK | 3,239,746 6.800% | 736,769 (+29.44%) | Filing History |
| 2023-07-07 4:00 pm Purchase | 2023-06-28 | 13G | Axsome Therapeutics, Inc. AXSM | Fairmount Funds Management LLC | 2,344,980 5.000% | 333,333 (+16.57%) | Filing History |
| 2023-02-14 5:11 pm Sale | 2022-12-31 | 13G | Axsome Therapeutics, Inc. AXSM | Venrock Healthcare Capital Partners II L.P. | 0 0.000% | -2,333,975 (Position Closed) | Filing History |
| 2023-02-14 4:06 pm Sale | 2022-12-31 | 13G | Axsome Therapeutics, Inc. AXSM | Partner Fund Management L.P. | 1,391,831 3.200% | -767,902 (-35.56%) | Filing History |
| 2023-02-14 3:45 pm Sale | 2022-12-31 | 13G | Axsome Therapeutics, Inc. AXSM | Fairmount Funds Management LLC | 2,011,647 4.600% | -155,000 (-7.15%) | Filing History |
| 2023-02-14 10:07 am Purchase | 2022-12-31 | 13G | Axsome Therapeutics, Inc. AXSM | RTW INVESTMENTS LP | 2,980,482 6.900% | 2,980,482 (New Position) | Filing History |
| 2023-02-09 11:07 am Purchase | 2022-12-30 | 13G | Axsome Therapeutics, Inc. AXSM | VANGUARD GROUP INC | 3,417,628 7.870% | 732,006 (+27.26%) | Filing History |
| 2023-02-01 4:54 pm Purchase | 2022-12-31 | 13G | Axsome Therapeutics, Inc. AXSM | BlackRock Inc. BLK | 2,502,977 5.800% | 393,355 (+18.65%) | Filing History |
| 2022-10-25 9:09 pm Purchase | 2022-09-16 | 13G | Axsome Therapeutics, Inc. AXSM | Fairmount Funds Management LLC | 2,166,647 5.400% | 2,166,647 (New Position) | Filing History |
| 2022-10-24 4:01 pm Purchase | 2022-10-14 | 13G | Axsome Therapeutics, Inc. AXSM | Partner Fund Management L.P. | 2,159,733 5.400% | 2,159,733 (New Position) | Filing History |
| 2022-02-09 3:24 pm Purchase | 2021-12-31 | 13G | Axsome Therapeutics, Inc. AXSM | VANGUARD GROUP INC | 2,685,622 7.130% | 44,548 (+1.69%) | Filing History |
| 2022-02-03 4:41 pm Sale | 2021-12-31 | 13G | Axsome Therapeutics, Inc. AXSM | BlackRock Inc. BLK | 2,109,622 5.600% | -170,144 (-7.46%) | Filing History |
| 2022-01-18 3:45 pm Sale | 2021-12-31 | 13G | Axsome Therapeutics, Inc. AXSM | IRIDIAN ASSET MANAGEMENT LLC | 0 0.000% | -2,064,158 (Position Closed) | Filing History |
| 2021-02-10 10:39 am Purchase | 2020-12-31 | 13G | Axsome Therapeutics, Inc. AXSM | VANGUARD GROUP INC | 2,641,074 7.070% | 2,641,074 (New Position) | Filing History |
| 2021-02-04 08:32 am Purchase | 2020-12-31 | 13G | Axsome Therapeutics, Inc. AXSM | IRIDIAN ASSET MANAGEMENT LLC | 2,064,158 5.500% | 2,064,158 (New Position) | Filing History |
| 2021-01-28 5:55 pm Purchase | 2020-12-31 | 13G | Axsome Therapeutics, Inc. AXSM | BlackRock Inc. BLK | 2,279,766 6.100% | 119,520 (+5.53%) | Filing History |